Pub. Date : 2005 Oct 10
PMID : 16186052
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The introduction of a highly efficacious new statin, rosuvastatin, may enable more patients to be treated to LDL-C goal within a fixed budget. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |
| 2 | OBJECTIVES: To compare the cost-effectiveness of rosuvastatin 10 mg and atorvastatin 10 mg in lowering LDL-C and achieving guideline goals after 12 weeks of treatment. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |
| 3 | RESULTS: Treatment with rosuvastatin 10 mg costs 1.85 per 1% reduction in LDL-C, compared with 2.37 per 1% reduction with atorvastatin 10 mg. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |
| 4 | The average costs per patient treated to the European LDL-C goals were 130.18 for rosuvastatin 10 mg and 242.44 for atorvastatin 10 mg. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |
| 5 | CONCLUSIONS: Rosuvastatin has the same acquisition costs as and is more efficacious than atorvastatin in lowering LDL-C and treating patients to target LDL-C levels. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |
| 6 | CONCLUSIONS: Rosuvastatin has the same acquisition costs as and is more efficacious than atorvastatin in lowering LDL-C and treating patients to target LDL-C levels. | Rosuvastatin Calcium | component of oligomeric golgi complex 2 | Homo sapiens |